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Abstract
Background: Nurses at The Norwegian Radium Hospital have reported that some patients notice
an unpleasant smell or taste in accordance with flushing of intravenous lines with commercially
available prefilled syringes. We have conducted a study in healthy volunteers to investigate the
occurrence, consistency and intensity of this phenomenon.
Methods: A randomised, blinded, crossover study comparing commercial available prefilled saline
9 mg/ml syringes to saline 9 mg/ml for injection in polyethylene package was performed in 10
healthy volunteers. The volunteers were given intravenous injections of varying volume and speed.
Data were analysed using descriptive statistics, and also Wilcoxon Signed Rank Test to compare
groups.
Results: After intravenous injection, 2 of 15 recordings demonstrated any sensation of smell or
taste after injection of saline from polyethylene package, while 14 of 15 recordings noted a
sensation after injection of saline from prefilled syringes. The intensity of the unpleasant sensation
was rated significantly higher after injection of saline from prefilled syringes compared to saline
from polyethylene (p = 0.001).
Conclusions:  Injection of saline from prefilled syringes in healthy volunteers resulted in an
experience of bad taste or smell. It is important that nurses and health workers are aware of the
phenomenon as described in this article in order to choose the preferred product for a given
patient.
Background
In order to maintain the patency of vascular access devices
like intravenous cannulaes and central venous lines, these
devices are regularly flushed with saline [1]. Commer-
cially available prefilled syringes are in some institutions
used to ease the work of the nursing staff. In addition,
there have been arguments in favour of these prefilled
saline syringes regarding decreased risk of infection and
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medication errors [2]. In addition, there are organizations
and regulatory agencies in some countries that recom-
mend the use of single dose containers for all medications
including catheter flushing and locking solutions. How-
ever, nurses report that some patients notice an unpleas-
ant smell or taste in accordance with the flushing
procedure. This is also mentioned in the Instruction for
Use enclosed in the package, where it is noted "Some
patients may experience a transitory taste or odour during
flushing. This minor effect ceases shortly after the proce-
dure."
We have conducted a study in healthy volunteers to inves-
tigate the occurrence of this phenomenon and the consist-
ency and intensity of the experience.
Methods
A literature search regarding prefilled saline syringes and
experience of unpleasant taste, flavour, or odour was car-
ried out. Becton Dickinson Pharmaceutical Systems was
contacted for possible background information.
A High performance liquid chromatography (HPLC)
analysis of saline from BD Saline XS (Becton Dickinson,
10 ml pre-filled syringe) and from Mini-Plasco® connect
(B. Braun, 20 ml polyethylene bottle) was conducted.
Fifty microliters of sample was injected on an Agilent
1100 system and separated through a 0.46 × 10 cm C18
Prodigy ODS column using a linear gradient from 10% to
90% acetonitrile in water over 30 minutes. Drift and back-
ground was corrected using 18.2 MΩ/cm Milli-Q water).
Then, a randomised, blinded, crossover study comparing
prefilled syringes (BD Saline XS, Becton Dickinson
[BDs]), to normal saline (from B. Braun, in polyethylene
packaging [rSaline]) was performed. 10 healthy volun-
teers participated, 2 male and 9 female, age 27 to 58. Writ-
ten informed consent was obtained from all participants.
Randomisation list was constructed from Research Rand-
omizer http://www.randomizer.org/form.htm. The vol-
unteers were asked to describe taste and smell after an
injection of the two different types of saline (BDs and rSa-
line). Since this was done in a cross-over fashion (5 volun-
teers were given BDs - rSaline - BDs, and 5 volunteers
rSaline - BDs - rSaline), 15 registrations were recorded for
each test. For each experiment we registered taste or smell
with Yes or No. We also used a Numeric Rating Scale
where 0 represents no bad taste or smell what so ever and
10 represents the worst taste or smell conceivable. The
volunteers were given the following categories of smell
and taste to describe their experience: Bitter, sweet, sour,
salt, metallic, stale, nauseous. The volunteers were also
given the opportunity to describe taste/smell with their
own words.
The experiment was conducted in the following manner:
An intravenous cannula was inserted into the arms of the
volunteers. The volunteers were blindfolded. They were
given a 10 ml intravenous injection of BDs or rSaline, in
the course of 5 seconds. The volunteers gave feedback on
the extent of the smell and/or taste they experienced after
receiving the injection. The same procedure for the second
and third injection was used. All three injections (of BDs
and rSaline) were given in a random order.
After 15 minutes one injection of 10 ml BDs was given to
all volunteers within a 30 second period. Finally, (after 15
minutes) one injection of 3 ml of BDs was given to all vol-
unteers within a 3 second period. The purpose with the
different injections was to register if the degree of any
smell/taste was influenced by low/high injection speed or
low/high volume (ml).
The volunteers flushed their mouths with tap water after
each test.
The healthy volunteers received 30 € to participate in the
project.
The Regional Committees for Medical Research Ethics in
Norway and the Norwegian Social Science Data Services
approved the study.
Statistics
SPSS software, version 16.0 (SPSS, Chicago, IL), was used
for statistical analyses. Descriptive data and Wilcoxon
Signed Rank Test (2-tailed) were applied since normal dis-
tribution was not guaranteed and we tested a small
number of volunteers. A P value < 0.05 was regarded as
statistically significant.
Results
A literature search in PubMed, EMBASE and SveMed using
the search terms, Becton Dickinson, prefilled syringes,
saline, odour, and taste (single terms and in combina-
tion), revealed no published articles addressing this phe-
nomenon.
Chromatograms from HPLC-analysis conducted in our
laboratory revealed that both products tested contained a
number of unidentified substances generating chromato-
graphic peaks (fig. 1).
Information from Becton Dickinson showed that the pres-
ence of volatile substances in the plastic material of the
syringes was discovered in 2001 and that these substances
were linked to the experience of minor reactions like bad
taste or smell. Becton Dickinson concluded that these sub-BMC Nursing 2010, 9:1 http://www.biomedcentral.com/1472-6955/9/1
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stances represented no toxic or pharmacological risk to
patients' health. The identification and saline-solution
concentrations provided by Becton Dickinson were: 2-
methyl-2-propanol: 8.5 ppm; 2-methyl-2-butanol: 0.7
ppm; ethyl-buthyl-ether: 0.4 ppm.
Two of 15 recordings demonstrated any sensation (smell/
taste) after injection of rSaline, while 14 of 15 recordings
noted a sensation after injection of BDs. Stale, metallic
and sweet were the standard descriptors most used. In
addition 4 persons used the word plastic. The intensity of
an unpleasant sensation after injection of BDs 10 ml over
5 seconds was rated significantly higher compared to rSa-
line, 10 ml over 5 seconds (p = 0.001), see figure 2. BDs
10 ml over 30 seconds and BDs 3 ml over 3 seconds are
demonstrated in figure 3. Although the sensation when
injected at slower speed, or less volume was lower than
with 10 ml over 5 seconds, these differences were not sta-
tistical significant compared to an injection of 10 ml BDs
over 5 seconds.
Discussion
Injection of saline from BD-syringes resulted in a sensa-
tion of bad taste or odour in most volunteers.
The phenomenon of bad taste or smell is explained by the
mechanism of volatile substances, released from saline
when injected into the bloodstream and then eliminated
by the respiratory system and thus detected by the patients
in the air expired by the olfactory system. A sensation of
taste, mediated by the taste buds, is usually combined
with stimulation of touch and smell. Thus it is not surpris-
ing that the volunteers confused taste, flavour, and odour.
We cannot find any documentation regarding the fre-
quency or the intensity of this unpleasant experience after
Chromatograms of saline from BD Saline XS (-) and from Mini-Plasco® connect (-) Figure 1
Chromatograms of saline from BD Saline XS (-) and from Mini-Plasco® connect (-). Detection by UV-absorbance 
at 240 nm. Acetonitrile gradient from 10% to 90% as indicated by solid line. Drift and background was corrected using 18.2 
MΩ/cm Milli-Q water.BMC Nursing 2010, 9:1 http://www.biomedcentral.com/1472-6955/9/1
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flushing of saline with these prefilled syringes. The phe-
nomenon is probably underreported as few patients will
find it logical to associate an unpleasant odour with flush-
ing of intravascular devices.
The chromatographic peaks demonstrated in the HPLC-
analysis (fig. 1) identify substances in the saline (from
BD-syringes) that are not found in regular saline. Whether
these peaks represent the volatile substances are likely, but
not established.
According to Becton Dickinson, these volatiles substances
(2-methyl-2-propanol: 8.5 ppm, 2-methyl-2-butanol: 0.7
ppm, ethyl-buthyl-ether: 0.4 ppm) present no toxic or
pharmacological risk to the patient's health even when
administered in dosages 1000 times that observed with
normal flushing.
However, these effects can be unpleasant for the patients,
and might be even worse in nauseated patients whether
from anaesthesia or chemotherapy. Probably, the experi-
ence is especially disturbing for cancer patients under
lengthy chemotherapy who often are more sensitive to
taste perceptions [3].
It is claimed from Becton Dickinson that the effect usually
can be avoided by using a flushing procedure with a
slower flow rate or smaller volume (Becton Dickinson -
Box plot of volunteers' experience of intensity of unpleasant taste or odour after injection of 10 ml saline (during 5 seconds)  from prefilled syringes from Becton Dickinson (BDs) and regular saline from polyethylene bottles (rSaline) Figure 2
Box plot of volunteers' experience of intensity of unpleasant taste or odour after injection of 10 ml saline (dur-
ing 5 seconds) from prefilled syringes from Becton Dickinson (BDs) and regular saline from polyethylene bot-
tles (rSaline). Y-axis: Numeric rating scale where 0 = no smell or taste and 10 = worst taste or smell conceivable.BMC Nursing 2010, 9:1 http://www.biomedcentral.com/1472-6955/9/1
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personal communication). This was not the case in our
study. A limitation is the small number of experiences
with low injection rate and small volume.
The benefit of prefilled syringes could improve clinician
work flow and reduced time required to prepare flush
syringes. Furthermore, labeling as part of the manufactur-
ing process increases patient safety. Potential reduction in
microbial contamination when used for vascular access
devices is also an attractive argument, although documen-
tation from good clinical controlled studies are lacking.
However, infectious outbreaks have been associated with
improper use of multiple dose vials of saline and heparin.
As mentioned previously, different organizations and reg-
ulatory agencies in some countries (particularly in the
United States) recommend the use of single dose contain-
ers for medications including flushing solutions. This
means that prefilled syringes are the only options in many
places. When weighing the overall risk versus benefits of
prefilled syringes, the issue of altered taste could be
argued to represent a minor complaint compared to the
potential benefits or reduced risk of infection and medica-
tion errors.
Conclusion
Injection of BD-saline in healthy volunteers resulted in an
experience of bad taste or smell. When considering the
pros and cons of prefilled saline syringes, this phenome-
Box plot of volunteers' experience of intensity of unpleasant taste or odour after injection of 10 ml saline (during 30 seconds)  and injection of 3 ml (during 3 seconds) from prefilled syringes from Becton Dickinson (BDs) Figure 3
Box plot of volunteers' experience of intensity of unpleasant taste or odour after injection of 10 ml saline (dur-
ing 30 seconds) and injection of 3 ml (during 3 seconds) from prefilled syringes from Becton Dickinson (BDs). 
Y-axis: Numeric rating scale where 0 = no smell or taste and 10 = worst taste or smell conceivable.Publish with BioMed Central    and   every 
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non should be taken into consideration. The manufactur-
ers of these prefilled saline syringes should find ways to
reduce the phenomenon.
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